Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Alfred Geller
Lsu Health Sciences Center, Department: Ophthalmology
Should you be removed from our database? Contact us at [email protected]. Read more below.
Alkermes, Inc.
Equity Interest - Publicly traded entity (e.g., stock, stock option, or other ownership interest)
Dr. Alfred Geller is the principal investigator on the above referenced grant sponsored by the NIH-NINDS. The goal of this project is to develop targeted gene transfer across specific synapse types for elucidating disease etiologies, developing gene therapies, and basic neuroscience. As required by CM-35, Dr. Geller disclosed that he has an equity interest in a company, Alkermes, Inc., whose business interest are related to this research. Alkermes, Inc. develops methods for long-term delivery of drugs across the blood brain barrier. In particular, Alkermes, Inc. develops drugs for major clinical conditions specifically focused on central nervous system disorders, such as schizophrenia, depression, addiction, and multiple sclerosis.
Targeted gene transfer across specific synapse types
This project will develop targeted gene transfer that can deliver different genes into presynaptic neurons and a selected subset of their postsynaptic neurons, based on both projection area and synapse type. This technology will benefit gene therapies for neurological diseases, elucidating the etiology of these diseases, and analyses of neuronal circuits, behaviors, and learning.
Filed on March 07, 2017.
Tell us what you know about Alfred Geller's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.